Abstract

145P An engineered ligand-trap biologic targeting the CD47 signaling pathway for cancer treatment with superb efficacy and safety profiles

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call